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a b s t r a c t
Background and objectives: HPV vaccination coverage is lower than that of other adolescent vaccines in
the southern US. This study sought to characterize caregiver attitudes associated with adolescent HPV
vaccination in the southern US and to inform interventions to promote HPV vaccination.
Methods: From December 2019 – January 2020, caregivers of adolescents (ages 9–17 years) living in thirteen southern US states were recruited from a nationally-representative online survey panel. Caregivers
(N = 1,105) completed a cross-sectional survey that assessed general adolescent vaccine attitudes as well
as those associated with the HPV vaccine and HPV vaccination decision-making. The primary study outcome was adolescents’ receipt of at least one dose of the HPV vaccine.
Results: Caregivers with vaccinated adolescents had greater positive attitudes towards adolescent vaccines compared to caregivers of unvaccinated adolescents. Top three areas of concern among caregivers
were related to vaccine ingredients, perceptions that adolescents receive too many vaccines, and worry
about vaccine side effects. In multivariable regression models, positive attitudes towards the HPV vaccine
and HPV vaccination decision-making strongly associated with HPV vaccination in addition to general
adolescent vaccination attitudes. Caregivers’ reported discomfort with discussing the topic of sex was
predictive of lower vaccination uptake for older adolescents.
Conclusions: Public health messaging in the southern US should be tailored to reduce concerns about vaccine safety and to communicate the importance of timely HPV vaccination. Campaigns that deliver information specific to the HPV vaccine and to support vaccination decision-making may be more effective
than those delivering only general adolescent vaccination information at promoting on-time HPV
vaccination.
Ó 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction
Despite the effectiveness of the Human Papillomavirus (HPV)
vaccine as a cancer-prevention strategy, only 1 in 2 adolescents
in the United States (US) is up-to-date with vaccination [1,2].
While HPV vaccination coverage is increasing steadily in the US,
⇑ Corresponding author at: 2200 W. Main Street, Suite 600, Durham, NC 27710,
USA.
E-mail address: lavanya.vasudevan@duke.edu (L. Vasudevan).

current numbers fall short of the Healthy People goal of 80% upto-date coverage by 2030 [2,3]. Recent studies suggest that parental attitudes rather than vaccine access is a key driver of HPV vaccine uptake among adolescents [2,4]. Nationally, HPV vaccination
coverage lags behind the coverage of other adolescent vaccinations
suggesting that HPV-specific attitudes may influence uptake
[2,5,6].
Negative parental attitudes towards vaccines are a well-known
contributor to vaccine hesitancy – the decision to intentionally
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survey panel [28]. Panel members self-administered the study survey online using the QualtricsXM survey platform.
Ethical approval
The study protocol was approved by the Duke University Health
System (DUHS) Institutional Review Board (Pro00101137) and the
University of South Carolina Institutional Review Board (Authorization agreement for reliance on DUHS IRB; Pro00085811). Since
the Centers for Disease Control and Prevention (CDC) only had
access to de-identified data, it was determined that the CDC was
not engaged in human subjects research and CDC’s IRB approval
was not required.

delay or refuse vaccinations [7]. A recent study assessing trends in
NIS-Teen data identified negative parental attitudes and a lack of
knowledge about HPV vaccine recommendations as the primary
reasons for non-vaccination of adolescents [8]. Examples of negative parental attitudes include concerns about HPV vaccine safety
and side effects, backlash against HPV vaccine mandates, religious
objections to vaccination, belief that HPV vaccination promotes
sexual promiscuity in vaccinated adolescents, and low perceived
risk of HPV infection or HPV-related cancers [4,8–11]. The presence
of vaccine concerns can be worsened by the exposure to misinformation and false vaccine controversy [12,13] Hence, the proactive
identification and mitigation of negative parental attitudes is critical for closing the gaps in HPV vaccination coverage among adolescents [14].
Southern US Health and Human Services (HHS) regions 4 and 6
have a high burden of HPV-attributable cancers but some of the
lowest up-to-date adolescent HPV vaccination coverage rates in
the country (50.3% and 49.6%, respectively) [15]. In a recent study
of vaccine hesitancy across the US, Santibanez et. al reported some
of the highest prevalence of vaccine hesitancy (>15%) among parents residing in the southern US [16]. Although that study examined parental vaccine hesitancy in the context of the influenza
vaccine, the trends are concerning in light of the low HPV vaccination coverage among adolescents in the southern US. Contextualizing drivers of negative parental attitudes toward HPV vaccination
in the southern US could yield important insights to guide public
health messaging in the region and to improve adolescent vaccine
uptake [17].
Several validated and widely used measures of parental attitudes towards adolescent vaccines, including the HPV vaccine,
have been described in the literature [18–26]. Limitations of existing measures include their focus on specific sub-populations such
as immigrant families, male [24] or female [21] adolescents, or
those of Hispanic ethnicity, assessment of general adolescent vaccine beliefs [18,20,22], and lack of up-to-date safety and efficacy
estimates for the HPV vaccine or guidelines for HPV vaccination
[19,25]. Since HPV vaccine-specific attitudes may be driving parental decisions, there is a need to review and adapt existing measures
to reflect up-to-date guidelines and evidence on HPV vaccination
and targeted to parents in general.
As part of a larger study on HPV vaccination disparities in the
southern US, we conducted a cross-sectional survey to characterize
caregiver attitudes and their associations with adolescent HPV vaccination. Attitudes were assessed using items from the existing literature on HPV vaccine attitudes, adapted to appeal to the general
population and updated to reflect the most recent guidelines and
data on HPV vaccination. The adapted items assessed a range of
caregiver attitudes, including general attitudes towards adolescent
vaccines, and attitudes specifically associated with the HPV vaccine, and HPV vaccination decision-making.

Participants and recruitment
To be eligible to take the survey, panel members had to be at
least 18 years of age, reside in one of 13 states in the southern
US (Department of Health and Human Services, HHS, regions 4
and 6; Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana,
Mississippi, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas), and be a parent or legal guardian
(henceforth ‘‘caregiver”) of an adolescent between 9 and 17 years
of age. The survey was only available in English. Panel members
received a link to the survey via email, and recruitment continued
until the sample size target was reached.
Sample size and justification
Due to the exploratory nature of the survey, the target sample
size was derived from a purposive sample estimate of 1,000 caregivers meeting eligibility criteria who were available in the survey
panel in the 13 states as well as the anticipated survey response
rates.
Data sources/measurement
When responding to the survey questions, caregivers were
asked to refer to their child who was between the ages of 9–
17 years at the time of the survey (henceforth ‘‘adolescent”) and
who had the most recent birthday at the time of the survey. Demographic data of caregivers and survey weights to ensure representativeness of the target population were provided by the online
survey panel company. All other data presented in this analysis
reflect self-reported responses of caregivers from the survey. The
survey included questions about caregivers’ and adolescents’
socio-demographic characteristics, adolescents’ vaccination status,
and caregivers’ attitudes towards adolescent vaccines in general,
HPV infection, the HPV vaccine, and HPV vaccination decisionmaking. The primary outcome was the receipt of  1 dose of the
HPV vaccine. HPV vaccination intention was assessed for caregivers of unvaccinated adolescents as well as those who did not
complete all HPV vaccine doses. Details of caregiver and adolescent
characteristics and HPV vaccination intention are published elsewhere [5].
The study team reviewed existing measures of caregiver attitudes [18–26] and grouped assessment items (henceforth referred
to as ‘items’) in three categories: general adolescent vaccination
attitudes, HPV vaccine-specific attitudes, and attitudes related to
HPV vaccination decision-making (see Box 1). Items were reviewed
for relevance to ensure that they reflected the most recent evidence and adolescent vaccination guidelines in the US at the time
the survey was fielded. For instance, items about the newness of
the HPV vaccine [19] or an exclusive focus on the vaccine recommendation for girls [19] were considered not relevant. The wording
of each item was also reviewed to ensure relevance to the general
US population (i.e., when the original item focused on a specific
subpopulation), and edited for brevity, clarity, and consistency

Methods
The detailed methods of this study have been reported previously in accordance with the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) statement for
cross-sectional studies and presented in Supplementary Table 1
[5,27]. Key information relevant to the analyses are described
below.
Study design and setting
From December 2019 – January 2020, caregivers (parents and
legal guardians) of adolescents (ages 9–17 years) were recruited
from 13 southern states through a nationally-representative online
2
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of vaccine-preventable diseases, number of recommended vaccines, risk of side effects, and trust in healthcare providers. The Likert
response scale for this measure ranged from 0 (strongly disagree)
to 10 (strongly agree) to match the original validated measure.
Two items (‘‘Adolescents receive too many vaccines” and ‘‘If I vaccinate my adolescent, he/she may have serious side effects”) were
phrased negatively compared with other items in the measure.
These negatively worded items were reverse coded to match other
items such that higher scores reflected more positive attitudes. To
reflect caregiver concerns about vaccine ingredients [30], a ninth
item ‘‘I worry about the ingredients in vaccines” was added to
the measure by the study team. This item was negatively worded,
and hence, also reverse scored such that higher scores reflected
more positive attitudes towards adolescent vaccines.
HPV vaccine-specific attitudes. Since HPV vaccination coverage
rates lag those of other adolescent vaccinations, the team decided
to include items that captured concerns or negative attitudes that
were specifically associated with the HPV vaccine. These items
were adapted from published measures and edited as previously
described (see Box 1). Items focused on perceptions of vaccine
effectiveness, immediate, long-term, and non-specific risks, adequacy of research, conflicts of interest, and conspiracy beliefs.
The responses to these items were captured using a 5-point Likert
scale ranging from 1 (strongly agree) to 5 (strongly disagree). Since
all items were negatively worded, greater disagreement with items
(i.e., higher scores) indicated more positive attitudes towards the
HPV vaccine.
Attitudes related to HPV vaccination decision-making. To capture caregiver attitudes that were related to HPV vaccination
decision-making, the team compiled 8 items related to the perceived severity of HPV infection, acceptability with age of vaccine
recommendation, vaccination as norm, social support for the vaccination decision, provider recommendation for the vaccine,
knowledge sufficiency, consent for vaccination and acceptability
of school mandates. The responses to these items were captured
using a 5-point Likert scale ranging from 1 (strongly agree) to 5
(strongly disagree). One item was reverse scored (see Box 1) such
that lower scores indicated more positive attitudes. In the final
analysis, a reverse combined mean score was generated to match
the other two measures where higher scores indicate more positive
attitudes.

Box 1: Survey assessment items on caregiver attitudes.
General adolescent vaccination attitudes (9 items,
0-strongly disagree to 10-strongly agree)
Vaccines are necessary to protect the health of
adolescents.
Vaccines do a good job in preventing the disease they are
intended to prevent.
Vaccines are safe.
If I do not vaccinate my adolescent, he/she may get a disease and cause other adolescents or adults also to get the
disease.
Adolescents receive too many vaccines.a.
If I vaccinate my adolescent, he/she may have serious side
effects.a.
In general, medical professionals in charge of vaccinations
have my adolescent’s best interest at heart.
I have a good relationship with my adolescent’s health
care provider.
I worry about the ingredients in vaccines.a.
HPV vaccine-specific attitudes (7 items, 1-strongly agree
to 5-strongly disagree)
The HPV vaccine is not very effective.
The HPV vaccine may lead to long-term health problems.b.
The HPV vaccine is being pushed to make money for pharmaceutical companies.
There has not been enough research done on the HPV
vaccine.
The HPV vaccine is/may be too painful for my child.b.
HPV vaccine is harmful.b.
The dangers of HPV vaccine are being covered up by the
government and pharmaceutical companies.b.
HPV vaccination decision-making attitudes (8 items, 1strongly agree to 5-strongly disagree)
The HPV infection is not severe enough to warrant
vaccination.
Children are getting the HPV vaccine too early.b, c.
Vaccinating my adolescent against HPV is a good thing to
do for their health.b.
People who are important to me support vaccinating my
adolescent against HPV.b.
My adolescent’s health care provider thinks that I should
vaccinate my adolescent against HPV.b.
I feel I have enough knowledge to make an informed decision about my adolescent’s HPV vaccination.b.
I am OK with my adolescent getting the HPV vaccine without my consent.
HPV vaccination should be required by my adolescent’s
school.
Footnotes: HPV: Human Papillomavirus. aItems were
reverse coded such that higher scores reflect positive attitudes. bItem wording updated from original to reflect up-todate guidelines on HPV vaccination for adolescents, improve
clarity, brevity or comprehension. cItems were reverse coded
such as lower scores reflect negative attitudes.

Survey weights and external validity
Geo-demographically calibrated weights were provided by the
online survey panel company [31] and applied to the data to correct for any sampling biases and to ensure the representativeness
of the survey findings to the target population, households with
adolescents ages 9–17 years in the southern US.
Statistical methods
Survey data were analyzed using SAS 9.4 (SAS Institute, Cary,
NC) with bivariable and multivariable survey-analytic regression
methods. Receipt of  1 dose of the HPV vaccine (‘‘yes” vs. ‘‘no”)
was the primary dependent variable.
For each of the three caregiver attitude measures, the distribution of response options by item was computed and plotted to
illustrate any differences among the vaccinated and unvaccinated
groups. In addition, a mean score and standard deviation was calculated for each item individually and a combined mean score was
generated for each measure for comparing caregiver attitudes in
the vaccinated and unvaccinated groups. Where relevant, items
were reverse scored prior to the calculation of the combined mean
score (see Box 1). Parametric (v2) tests were used to compare
weighted differences between the vaccinated and unvaccinated

with other items (see Box 1). Likert scales for responses were chosen to match the original validated measures when possible or
restricted to 5 points for brevity and to reduce burden on survey
takers.
General adolescent vaccination attitudes. A total of nine items
were included in this measure, eight of which were included as is
from a previously validated measure of general caregiver attitudes
towards adolescent vaccines [29]. These eight original items covered caregiver attitudes about the need for adolescent vaccines,
vaccine effectiveness and safety, individual and community risk
3
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Table 1
Characteristics of caregivers (n = 987) from 13 southern states in the United States stratified by the HPV vaccination status of their adolescents.
Covariate

Age (mean(SD))
Gender (n (%))
Residenceb (n (%))
Education (n (%))

Currently working (n (%))
Has anyone you know ever had any of the following (n (%))

I am uncomfortable talking with my child about sex (mean(SD))
My child is not sexually active (mean(SD))

Level

Has your adolescent ever
received the HPV vaccine?
Yes
N = 368

No/Other
N = 619

Male
Female
Urban
Rural
Bachelor’s degree or higher
Less than Bachelor’s degree

44.03 (±7.61)
140 (37.9)
228 (62.1)
308 (83.7)
60 (16.3)
125 (33.9)
243 (66.1)

41.65 (±7.71)
255 (41.1)
365 (58.9)
486 (78.5)
133 (21.5)
202 (32.7)
417 (67.3)

Yes
No/Don’t know
HPV infection
HPV-related morbidity/cancersc
Other cancers
Other STIs
None of the above
Don’t know
Scale of 0-10d
Scale of 0-10d

284 (77.3)
83 (22.7)
88 (24)
164 (44.6)
148 (40.2)
97 (26.2)
103 (27.9)
23 (6.3)
2.95 ± (3.22)
7.95 (±3.14)

508 (82.1)
111 (17.9)
104 (16.8)
213 (34.4)
215 (34.7)
140 (22.5)
184 (29.7)
54 (8.8)
3.62 (±3.2)
8.77 (±2.41)

Parametric P-valuea

<0.001
0.32
0.05
0.70

0.07
0.006
0.001
0.09
0.19
0.54
0.17
0.002
<0.001

Abbreviations: HPV, Human Papillomavirus. SD, Standard deviation. Footnotes: Number of observations may not add up to 987 due to missing values on HPV vaccination
status or other variable of interest. n(%) reported unless otherwise noted. aThe parametric p-value is calculated by chi-square test. bRural-urban residence status was assigned
based on Census definition: https://www.census.gov/programs-surveys/geography/guidance/geo-areas/urban–rural.html. For 66 records with zip codes in non-residential
areas, rural–urban designation was based on the USDA FIPS code: https://www.ers.usda.gov/data-products/rural–urban-continuum-codes.aspx. cCombines response options
for abnormal PAP smear, cervical cancer/pre-cancer, anal cancer, and head/neck cancer. dScale of 0–10 where 0 indicates highest disagreement with item. Lower scores
indicate positive attitudes.

Fig. 1. Caregivers’ general attitudes towards adolescent vaccines, stratified by their adolescents’ HPV vaccination status. The Likert responses were on a scale of 0–10, where
0-strongly disagree to 10-strongly agree.

Weighted multivariable logistic regression models were used to
assess correlations between adolescents’ HPV vaccination status
and caregiver attitudes. Combined mean attitude scores for the
three measures (general adolescent vaccination attitudes, HPV

groups. Cronbach’s alpha was computed for each item and for the
combined item score for each measure to assess the internal consistency. An alpha value of 0.7 or greater was considered
acceptable.
4
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Fig. 2. Caregivers’ attitudes toward the HPV vaccine, stratified by their adolescents’ HPV vaccination status. The Likert responses were on a scale of 1–5, where 1-strongly
agree to 5-strongly disagree.

caregivers of unvaccinated adolescents reported that they were
uncomfortable talking with their adolescent about sex and that
their adolescent was not sexually active.
Fig. 1 and Supplementary table 2 show the responses to nine
items assessing caregivers’ general adolescent vaccination attitudes, with responses stratified by their adolescents’ HPV vaccination status. On a scale of 0–10, where higher scores indicated more
positive attitudes, caregivers of vaccinated adolescents had a
higher mean combined score (7.98 ± 1.53) compared with caregivers of unvaccinated adolescents (7.08 ± 1.97). More caregivers
of unvaccinated adolescents had concerns related to vaccine ingredients, the number of recommended vaccines, and vaccine side
effects. The items included in the general adolescent vaccination
attitude measure showed high internal consistency (see: supplementary table 2; Cronbach’s alpha = 0.87), hence the combined
mean score was used in multivariable analyses.
Fig. 2 and Supplementary table 3 show caregivers’ attitudes
towards the HPV vaccine, with responses stratified by their adolescents’ HPV vaccination status. On a scale of 1–5, where higher
scores reflected more positive attitudes, caregivers of vaccinated
adolescents reported a higher mean combined score (3.65 ± 0.8)
compared with caregivers of unvaccinated adolescents (3.01 ± 0.
75). Greatest concerns among caregivers of unvaccinated adolescents were related to the perceived inadequacy of research on
the HPV vaccine, perception that the HPV vaccine is not very effective, and the notion that the HPV vaccine was pushed to profit
pharmaceutical companies. The seven items included in this measure showed high internal consistency (see: supplementary table
3; Cronbach’s alpha = 0.89), hence the combined mean score was
used in multivariable analysis.
Fig. 3 and Supplementary table 4 show caregivers’ attitudes
related to HPV vaccination decision-making, with responses stratified by their adolescents’ HPV vaccination status. On a scale of 1–
5, lower scores represent positive attitudes. More caregivers of vaccinated adolescents reported perceived severity of HPV infection,

vaccine-specific attitudes and attitudes related to adolescent HPV
vaccination decision-making) were used as covariates. For all measures, higher mean scores represent positive caregiver attitudes.
Models controlled for key covariates that differed between the vaccinated and unvaccinated groups. Details of these covariates have
been previously published and include adolescent age, gender,
school type, caregivers’ employment status, travel time to usual
healthcare provider, and provider recommendation for the HPV
vaccine [5]. Odds ratios and 95% confidence intervals were computed to describe the extent to which differences in vaccination
rates were associated with systematic variation in covariates; pvalues < 0.05 were considered statistically significant. Missing values were excluded from the analysis.
We used weighted generalized linear mixed models to examine
associations between socio-demographic characteristics and outcome variables of attitudes. Error correlation within states were
accounted by clustering data at the state level. The extent to which
differences in caregivers’ attitudes were associated with variation
in predictor variables are described in estimates and standard
errors.

Results
The survey response rate was 55.2%; data from 987 caregivers
were included in the final analysis after excluding incomplete
responses and those from participants who did not meet inclusion
criteria.
Table 1 shows characteristics of caregivers stratified by the HPV
vaccination status of their adolescent. Approximately one in three
(37.3%; n = 368) caregivers reported that their adolescent had
received at least one dose of the HPV vaccine. Compared with caregivers of unvaccinated adolescents, more caregivers of vaccinated
adolescents were older on average, lived in an urban area, and
knew someone with HPV infection, morbidity, or cancer. More
5

L. Vasudevan, J. Ostermann, Y. Wang et al.

Vaccine: X 11 (2022) 100181

Fig. 3. Caregivers’ attitudes related to HPV vaccination decision-making, stratified by adolescents’ HPV vaccination status. The Likert responses were on a scale of 1–5, where
1-strongly agree to 5-strongly disagree.

Table 2
Association of caregivers’ attitudes and HPV vaccination among adolescents aged 9–17 years (N = 987) from 13 southern states in the United States.
Variablesa

OR (95% CI)
Unadjusted

p-value

aORb,c (95% CI)

p-value

General vaccine attitudes score
HPV vaccine attitudes score
HPV vaccination attitudes scored
My child is unlikely to get an HPV-related disease.
I am uncomfortable talking with my child about sex.
My child is not sexually active.

1.34 (1.15,1.57)
2.96 (1.93,4.54)
5.65 (3.84,8.29)
0.89 (0.82,0.96)
0.94 (0.89,0.99)
0.9 (0.86,0.94)

<0.001
<0.001
<0.001
0.003
0.02
<0.001

1.43
3.26
4.82
0.93
0.94
0.96

<0.001
<0.001
<0.001
0.10
0.02
0.25

(1.2,1.71)
(2.32,4.59)
(2.82,8.23)
(0.85,1.02)
(0.89,0.99)
(0.89,1.03)

Abbreviations: HPV; Human Papillomavirus. Footnotes: aCombined mean score for each scale used in the regression model. bModel adjusts for the following previously
known socio-demographic and healthcare access covariates: adolescent’s ethnicity/race, adolescent’s gender, adolescent’s age, adolescent’s school type, caregivers’ working
status, travel time to usual health care provider and provider recommendation for HPV vaccine. cChange in odds of vaccination for every 1 point increase in attitude score.
d
Reversed combined mean score used in the model such that higher score indicates positive attitudes.

Table 3
Association of caregiver attitudes and HPV vaccination among adolescents aged 9–10 years (N = 225, 22.8%) from 13 southern states in the United States.
Variablesa

OR (95% CI)
unadjusted

p-value

aORb,c (95% CI)

p-value

General vaccine attitudes score
HPV vaccine attitudes score
HPV vaccination attitudes scored
My child is unlikely to get an HPV-related disease.
I am uncomfortable talking with my child about sex.
My child is not sexually active.

1.11(0.65,1.91)
2.47(1.05,5.83)
1.36(0.47,3.91)
1.23(0.93,1.63)
0.73(0.46,1.16)
0.8(0.65,0.98)

0.70
0.04
0.57
0.15
0.18
0.03

4.33(1.45,12.98)
1.58(0.66,3.81)
3.93(0.36,43.35)
1.35(0.98,1.85)
0.9(0.58,1.38)
0.68(0.46,1)

0.009
0.30
0.26
0.07
0.63
0.05

Abbreviations: HPV; Human Papillomavirus. Footnotes: aCombined mean score for each scale used in the regression model. bModel adjusts for the following previously
known socio-demographic and healthcare access covariates: adolescent’s ethnicity/race, adolescent’s gender, adolescent’s age, adolescent’s school type, caregivers’ working
status, travel time to usual health care provider and provider recommendation for HPV vaccine. cChange in odds of vaccination for every 1 point increase in attitude score.
d
Reversed combined mean score used in the model such that higher score indicates positive attitudes.

tion without caregiver consent. Due to the high internal consistency of the eight items in this measure (see supplementary
table 4; Cronbach’s alpha = 0.84) the reversed combined mean
score was used in multivariable analysis.
Table 2 shows the results of the multivariable analysis examining the association of caregiver attitudes and adolescent HPV vac-

and social support and provider recommendation in favor of HPV
vaccination. Caregivers of vaccinated adolescents were more likely
to report self-efficacy in making an informed decision about HPV
vaccination compared with caregivers of unvaccinated adolescents. Caregivers of unvaccinated adolescents expressed lower
support for school mandates for HPV vaccination and for vaccina6
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Table 4
Association of parental attitudes and adolescent HPV vaccine uptake among adolescents aged 11–17 years (N = 762, 77.2%) from 13 southern states in the United States.
Variablesa

OR (95% CI)
unadjusted

p-value

aORb,c (95% CI)

p-value

General vaccine attitudes score
HPV vaccine attitudes score
HPV vaccination attitudes scored
My child is unlikely to get an HPV-related disease.
I am uncomfortable talking with my child about sex.
My child is not sexually active.

1.41(1.23,1.63)
3.17(2.05,4.92)
6.5(4.69,9.01)
0.88(0.8,0.97)
0.95(0.91,1.01)
0.94(0.88,1)

<0.001
<0.001
<0.001
0.01
0.08
0.04

1.46(1.23,1.73)
3.42(2.38,4.92)
5.38(3.34,8.67)
0.92(0.82,1.02)
0.94(0.89,0.99)
0.95(0.88,1.04)

<0.001
<0.001
<0.001
0.13
0.03
0.26

Abbreviations: HPV; Human Papillomavirus. Footnotes: aCombined mean score for each scale used in the regression model. bModel adjusts for the following previously
known socio-demographic and healthcare access covariates: adolescent’s ethnicity/race, adolescent’s gender, adolescent’s age, adolescent’s school type, caregivers’ working
status, travel time to usual health care provider and provider recommendation for HPV vaccine. cChange in odds of vaccination for every 1 point increase in attitude score.
d
Reversed combined mean score used in the model such that higher score indicates positive attitudes.

Fig. 4. Correlates of caregiver attitudes, by adolescent HPV vaccination status.

attitudes toward HPV and general vaccinations tended to be more
negative among families minoritized by racial and ethnic status
and among those with uninsured adolescents, and more positive
for those who had received a provider recommendation for the
HPV vaccine. Among the unvaccinated, attitudes tended to be more
negative for caregivers with higher education and those attending
religious services, adolescents in home/online schooling, and uninsured adolescents.

cination status. After adjusting for covariates related to caregiver
and adolescent characteristics, health care access, and provider
recommendation, the odds of HPV vaccination were higher for adolescents who had caregivers with more positive attitudes towards
adolescent vaccines generally, and towards the HPV vaccine and
HPV vaccination decision-making specifically. For caregivers of
younger adolescents (9–10 years), only general adolescent
vaccination attitudes were predictive of HPV vaccination (Table 3).
For caregivers of older adolescents (11–17 years), general adolescent vaccination attitudes as well as HPV vaccine and vaccination
attitudes were predictors of HPV vaccination. In this group, caregivers’ discomfort with discussing the topic of sex with the adolescent was a negative predictor of HPV vaccination (Table 4).
Attitudes varied systematically with select characteristics of
caregivers and adolescents (Fig. 4); associations differed between
vaccinated and unvaccinated adolescents. Among the vaccinated,

Discussion
Our study findings underscore the important role of caregiver
attitudes in the decision to vaccinate adolescents living in the
southern US [8]. In our study, positive caregiver attitudes towards
adolescent vaccines in general, towards the HPV vaccine and associated with HPV vaccination decision-making specifically, were
7
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bypass caregiver consent prior to vaccination. We did not assess if
the lower support reflected opposition for mandates in general or
whether they were reflective of early controversy and failed
attempts to mandate the HPV vaccine [37].
Our study has several strengths. First, it provides important
insights into caregiver attitudes towards HPV vaccination in the
southern US—the region with the lowest HPV vaccination coverage
in the US. Second, our study sample is drawn from a nationallyrepresentative panel of households and we use geodemographically calibrated weights to reduce sampling biases.
Third, we explore caregiver attitudes using three distinct measures
targeting general adolescent vaccination attitudes, HPV vaccinespecific attitudes and attitudes related to HPV vaccination
decision-making. Doing so allows us to explore attitudes that were
HPV vaccine specific and distinguish them from general adolescent
vaccination attitudes and attitudes related to HPV vaccination
decision-making. Future studies may use one or more of these
measures to assess caregiver attitudes related to HPV vaccination.
Finally, our study represents one of the last large regional surveys
on HPV attitudes prior to the COVID-19 pandemic. Thus, it provides
useful data for comparisons in an era during which COVID-19 vaccines are recommended for adolescents.
Study limitations with respect to the recall bias resulting from
caregivers’ report of adolescent vaccination status have been previously described [5]. Other limitations discussed previously include
caregivers’ self-reported eligibility and potential selection bias. As
noted earlier, use of Address-Based Sampling to generate online
survey panel as well as application of post-hoc, geodemographically-calibrated survey weights mitigate the latter limitation. Due to the cross-sectional nature of the survey, we are
unable to determine the proportion of caregivers who had positive
attitudes a-priori versus as a result of their adolescent’s HPV vaccination experience. In particular, attitudes related to concerns
about pain during vaccine administration may be influenced by a
positive or a negative vaccination experience. Further validation
of the measures used in this study with prospective cohorts that
allow for the measurement of caregiver attitudes prior to HPV vaccination initiation is important. Our sample included small numbers of vaccinated adolescents in the 9–10 age group and further
studies in this age group may be necessary to validate our findings.
In addition, our findings do not reflect attitudes of adolescents, and
there is currently limited literature on the role that adolescents,
especially those who are on the younger end of the spectrum, play
in decisions about vaccination.

strongly associated with higher odds of HPV vaccination. HPV vaccine and vaccination decision-making related attitudes were independently associated with HPV vaccination, even after controlling
for general vaccine attitudes. Overall, most caregivers reported
positive general attitudes toward adolescent vaccination in general. This finding is consistent with the high uptake of adolescent
vaccines such as Tdap and MenACWY. Notably, caregiver responses
reflected greatest concerns with vaccine ingredients, the number of
recommended adolescent vaccines, and vaccine side effects, with
more caregivers of unvaccinated adolescents reporting these concerns. These concerns mirror those identified in a national survey
of parental attitudes towards the HPV vaccine [4] Hence, public
health messaging should focus on emphasizing HPV vaccine safety
and need, especially for those caregivers who have not yet initiated
HPV vaccination for their adolescent.
Interestingly, our data reveal patterns of shifting concerns with
age of the adolescents. While caregivers of younger adolescents
(9–10 year olds) had concerns about adolescent vaccines in general, more specific concerns about the HPV vaccine and attitudes
related to vaccination decision-making appear to emerge for caregivers of older adolescents (11–17 years). In one study, despite
exposure to messaging that emphasized the role of HPV vaccination for cancer prevention, the sexually-transmitted nature of
HPV and perceived association with adolescents’ sexual activity
remained factors in caregiver decision to accept the vaccine [9].
Our study findings suggest caregivers’ discomfort in discussing
the topic of sex may contribute to delays or refusals of HPV vaccination for age-eligible adolescents. Hence, public health messaging
should clarify the reason for initiating HPV vaccination on time
and/or prior to sexual debut [9]. The Advisory Committee on
Immunization Practices (ACIP) recommendations allow for HPV
vaccination initiation as young as age 9 years. Further research is
needed to establish whether encouraging early initiation is a viable
and effective strategy for increasing HPV vaccination coverage.
Interestingly, only a minority of caregivers reported knowing
someone with a history of HPV infection. Thus education efforts
may also need to correct false perceptions about the rarity of
HPV infection, bridge potential knowledge gaps regarding the connection between HPV infection and cancer, and to reduce any associated stigma [32]. In addition, HPV vaccine-specific messaging as
opposed to generic vaccination promotion messages may be
needed to support caregivers’ decision to initiate HPV vaccination
for their adolescent children.
Compared with caregivers of unvaccinated adolescents, caregivers of vaccinated adolescents in our study were more likely to feel
like they had enough information to facilitate vaccination decisionmaking and to express support from people they valued and the
health provider in favor of vaccination. The need for enhanced training for providers to address caregivers’ concerns and provide strong
vaccine recommendation is supported by this and other studies
[33,34]. Prior findings of our study suggest that healthcare access
may influence completion rates [5]. Hence, strategies focused on
increasing completion rates need to address access barriers in
addition to caregiver attitudes. Caregiver characteristics associated
with HPV vaccination in our study may be particularly salient in
the context of the southern US, where higher proportions of Black
and religious populations and those living below the poverty line
have been documented [35,36]. In regions with lower healthcare
access (e.g., provider shortages, greater travel times to providers,
low health insurance coverage), it may also be important to identify
non-healthcare based sources of trust (e.g., school nurses, community organizations, religious leaders etc.) for communicating the
importance of HPV vaccination. Social media-based strategies could
also be leveraged to promote peer endorsement and social support
for vaccination [13]. Our findings suggest limited support among
caregivers for school mandates and for policies that propose to

Conclusion
Public health messaging in the southern US should be tailored
to reduce concerns about HPV vaccine safety and to communicate
the importance of timely HPV vaccination. Campaigns that deliver
HPV vaccine-specific information and messaging to support
vaccination decision-making may be more effective at promoting
on-time HPV vaccination than those delivering only general vaccine information.
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